Carregant...
Nicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease
BACKGROUND: Although 3,4-dihydroxyphenylalanine (L-dopa) is the gold-standard treatment for Parkinson’s disease, it can lead to disabling dyskinesias. Previous work showed that nicotine reduces L-dopa-induced dyskinesias (LIDs) in several parkinsonian animal models. The goal of this study was to det...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787977/ https://ncbi.nlm.nih.gov/pubmed/23836409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25594 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|